Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020

• Main Authors: Li Jun Thean (Author), Lucia Romani (Author), Daniel Engelman (Author), Handan Wand (Author), Adam Jenney (Author), Jyotishna Mani (Author), Jessica Paka (Author), Tuliana Cua (Author), Sera Taole (Author), Maciu Silai (Author), Komal Ashwini (Author), Aalisha Sahukhan (Author), Mike Kama (Author), Meciusela Tuicakau (Author), Joseph Kado (Author), Matthew Parnaby (Author), Natalie Carvalho (Author), Margot Whitfeld (Author), John Kaldor (Author), Andrew C. Steer (Author)
• Format: Book
• Published: Elsevier, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Scabies is an important predisposing factor of impetigo which can lead to serious bacterial complications. Ivermectin-based mass drug administration can substantially reduce scabies and impetigo prevalence in endemic settings, but the impact on serious bacterial complications is...